FDA Investigator Paraluman S Leonin

Paraluman S Leonin has inspections in 14 countries as of 16 Nov 2023. Paraluman S Leonin has collaborated with a combinined 5383 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
141
Last Inspection Date:
16 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100009453
Country:
Germany, Canada, United States of America, China, Spain, Italy, France, Russian Federation, India, Taiwan, Ireland, United Kingdom of Great Britain and Northern Ireland, Switzerland, Philippines
Co-Investigator(s):
Abby E Pelletier, Abdur Rafay Shareef, Aireen V Mendoza, Alan P Kurtzberg, Alan R Condon, Alice C Silva, Alice S Tsao, Alois P Provost, Amber G Wardwell, Amy C Jordan, Anastasia M Shields, Andre S Lamontagne, Andrew Le, Andrew M Barlow, Angela E Glenn, Anthony C Warchut, Anthony W Thomas, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Atul J Agrawal, Azza Talaat, Barbara G Swan, Barbara M Frazier, Bernice F Hirsch, Bernice Hirsh, Binh T Nguyen, Blondell W Johnson, Bogdan Kurtyka, Bradley D Newsad, Brenda P King, Brian D Nicholson, Brooke K Higgins, Camerson E Moore, Carl A Huffman, III, Carla C Tuite, Cassandra L Abellard, Celia N Cruz, Charisse K Green, Charles L Zhou, Cheryl A Clausen, Chilton L Ng, Chilton Ne, Chris A Sack, Christina Capacci Daniel, PhD, Constance Desimone, Courtney N Long, Craig T Rybus, Daniel L Zheng, Darin S Wiegers, Darren S Brown, Daryl A Dewoskin, David M Beltran, David P Vanhouten, Debra I Love, Debra L Pagano, Debre M Emerson, Dell S Moller, Demitria J Xiradakis, Dennis Cantellops Paite, Devaughn Edwards, Dien N Nguyen, Doan T Nguyen, PharmD, Donald L Lech, Dongping Dai, PhD, Donna J Clevenger, Dorothy W Lee, Douglas A Campbell, Douglas Florentino, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Dwaine Rieves, MD, Edmund F Mrak, Jr, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Eric L Dong, BS, Eric M Mueller, PharmD, Erik W Koester, Erin P Conlin, Felix Maldonado, Frederick Razzaghi, Garry H Stewart, Gary J Hagan, George J Flynn, George M Ibrahim, George Pyramides, George T Allen, Jr, Gerard D Difiore, German Rivera, Geroge J Flynn, Gregory D Dixon, Gwyn G Dickinson, Helen Verdel, Hien Albright, Holly Brevig, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James A Liubicich, James H Tanner, James L Dunnie, Jr, James P Mcreavey, Jamie S Mathews, Javier O Vega, Jawaid Hamid, Jay M Patria, Jennifer C Adams, Jessica L Pressley, Jianming Li, Joan A Loreng, Joey V Quitania, John A Sciacchitano, John L Zaccone, John P Mistler, John S Hartford, Jonathan G Matrisciano, Jorge L Guadalupe, Jose A Cruz, Jose A Torres, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Javier Tavarez, Jose M Cayuela, Jose O Hernandez, Jose R Hernandez, Joseph H Procopio, Junho Pak, Justin A Boyd, Justine M Corson, Justine Tomasso, Kalavati Suvarna, PhD, Karen A Briggs, Karen Mcnabb Noon, Katherine D Adams, Katherine Szestypalow, Kathleen E Mcafoose, Katie L Korchinski, Kenneth E Felkley, Kenneth H Williams, Kent A Conforti, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kristina J Donohue, Larry K Austin, Lata C Mathew, PhD, Laura L Staples, Lauren M Lawrance, Laurie B Frazier, LCDR Debra Emerson, Leanna M Slarsky, Leena Thomas, Leo B Zadecky, Leonin Paraluman, Linda F Murphy, Linda L Ng, Linda R Kuchenthal, Lisa M Bellows, Lorayne A Mcguinness, Lori M Newman, LT Tamara J Henderson, Lucila B Nwatu, Luella J Rossi, Luis A Dasta, M Patriciaurphy Murphy, Margaret E Walsh, Margaret M Sands, Marie F Morin, Mark C Lookabaugh, Mark E Parmon, Mark R Mcclain, Martin J Guardia, Marvin D Jones, Mary Jeanet Mcgarry, Marybet Lopez, Matthew B Casale, Matthew C Watson, Matthew D Silverman, Maya M Davis, Megan A Haggerty, Melba Trivera Clavell, Melissa J Garcia, Merideth K Rose, Michael A Charles, Michael L Casner, Michael P Anthony, Michael P Sheehan, Michael R Goga, Michele L Obert, Michele Perry Williams, Michelle M Noe, Michelle M Noe Varga, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Milva E Melendez, Minh D Phan, Monique C Lo, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nancy G Schmidt, Nealie C Newberger, Nebil A Oumer, Nichole B Murphy, Noreen Muniz, Pamela L Ogonowski, Paraluman Leonin, Parul M Patel, Patrick C Klotzbuecher, Patrick L Wisor, Paul L Bellamy, Paul P Geraci, Paula M Laplant, Peter C Chow, Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Pratik S Upadhyay, DDC, Qin Xu, Rachel C Harrington, Raeann R Wu, Ramon A Hernandez, Ramon E Martinez, Randy L Self, Raymond T Oji, Reba A Gates, Rebecca E Dombrowski, Regina T Brown, Richard B Mcaroy, Richard E Needham, Richard H Penta, Robert J Doyle, Robert J Martin, Robert Mo Brien, Rory K Geyer, Russell J Glapion, S Lori Brown, PhD MPH, Samantha J Bradley, Samina S Khan, Samuel K Mathew, Samuel Mathew, Samuel T Walker, Sandra P White, Sangeeta M Khurana, PhD, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Satheesh Thomas, Sean R Marcsisin, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shelby N Marler, Sherry M Nisson, Shirley S Wen, Simone E Pitts, Sixto M Mercado Rios, Stacey S Degarmo, State Agency, Stephen J Mottola, Stephen R Souza, Steven D Kehoe, Steven P Donald, Sunita Pandey, Susan M Jackson, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Suzanne M Healy, Sylvia A Craven, Tamil Arasu, PhD, Ted L Anderson, Teresa I Navas, Terry C Kimball, Thomas J Arista, Thomas W Nojek, Timothy T Kapsala, Tina M Pawlowski, Torrance J Slayton, Towanda L Terrell, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valentino Fiorella, Victor J Gangi, Victoria M Daddeo, Vilmary Negron Rodriguez, Vioela J Caze, Walden H Lee, Wayne E Seifert, Wen Ning Chan (Sally), William J Leonard, William K Dagley, Xiaokuang Lai, PhD, Xiomara Copeland, Ying Xin Fan, PhD, Yong Hu, Yumi J Hiramine, Yvette I Johnson, Yvonne Y Wu, Zhong Li, PhD

Paraluman S Leonin's Documents

Publish Date Document Type Title
March, 2009 FDA 483 NORTON (WATERFORD) LIMITED - Form 483, 2009-03-13
April, 2003 FDA 483 TEVA PFC - Form 483, 2003-04-02
April, 2008 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2008-04-04
August, 2012 FDA 483 Vertex Pharmaceuticals Incorporated - Form 483, 2012-08-02
November, 2005 EIR Huzhou Zhanwang Pharmaceutical Co., Ltd. - EIR, 2005-11-03
November, 2001 EIR Natural Pharmaceuticals, Inc. - EIR, 2001-11-06
March, 2000 FDA 483 Jeffrey Isner, M.D. - Form 483, 2000-03-22
November, 2005 FDA 483 Huzhou Zhanwang Pharmaceutical Co., Ltd. - Form 483, 2005-11-03
March, 2003 FDA 483 Response BASF Grenzach GmbH - Form 483R, 2003-04-03
January, 2010 FDA 483 Johnson Matthey Pharmaceutical Materials, Inc. - Form 483, 2010-01-15
April, 2003 FDA 483 Response Flamma SpA - Form 483R, 2003-04-30
March, 2003 EIR BASF Grenzach GmbH - EIR, 2003-03-20
October, 2005 FDA 483 Huadong Medicine Co. Ltd. - Form 483, 2005-10-20
December, 2011 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2011-12-09
August, 2006 FDA 483 First Boston Pharma LLC - Form 483, 2006-08-24
November, 2005 FDA 483 Response Huzhou Zhanwang Pharmaceutical Co., Ltd. - Form 483R, 2005-12-14
March, 2000 EIR Jeffrey Isner, M.D. - EIR, 2000-03-22
October, 2002 EIR Thomas J. Lynch, CI - EIR, 2002-10-10
June, 2012 FDA 483 Response Momenta Pharmaceuticals, Inc. - Form 483R, 2012-06-20
June, 2012 EIR Momenta Pharmaceuticals, Inc. - EIR, 2012-06-08
October, 2005 EIR Huadong Medicine Co. Ltd. - EIR, 2005-10-20
September, 2000 EIR AstraZeneca LP - EIR, 2000-09-08
January, 2002 EIR Timothy Cooley, M.D., Clinical Investigator - EIR, 2002-01-16
June, 2010 FDA 483 Confarma AG - Form 483, 2010-06-24
October, 2001 FDA 483 Boston Analytical - Form 483, 2001-10-04
April, 2003 EIR Flamma SpA - EIR, 2003-04-02
June, 2011 FDA 483 Boston Analytical - Form 483, 2011-06-16
June, 2009 FDA 483 Curia Massachusetts, Inc. - Form 483, 2009-06-12
February, 2008 FDA 483 Millennium Pharmaceuticals, Inc. - Form 483, 2008-02-21
June, 2012 FDA 483 Momenta Pharmaceuticals, Inc. - Form 483, 2012-06-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more